ID: ALA3645249

Max Phase: Preclinical

Molecular Formula: C32H39F4N5O3

Molecular Weight: 617.69

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN1C[C@@H](CN(C(=O)[C@@H]2CCCO2)[C@@H](c2nc(-c3cc(F)ccc3F)nn2Cc2cccc(F)c2)C(C)(C)OC)[C@@H](F)C1

Standard InChI:  InChI=1S/C32H39F4N5O3/c1-5-39-17-21(26(36)19-39)18-40(31(42)27-10-7-13-44-27)28(32(2,3)43-4)30-37-29(24-15-23(34)11-12-25(24)35)38-41(30)16-20-8-6-9-22(33)14-20/h6,8-9,11-12,14-15,21,26-28H,5,7,10,13,16-19H2,1-4H3/t21-,26-,27-,28-/m0/s1

Standard InChI Key:  BXBCAGBSQBGQLP-FYYOVZQQSA-N

Associated Targets(Human)

Kinesin-like protein 1 1720 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 617.69Molecular Weight (Monoisotopic): 617.2989AlogP: 5.17#Rotatable Bonds: 11
Polar Surface Area: 72.72Molecular Species: NEUTRALHBA: 7HBD: 0
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.43CX LogP: 4.99CX LogD: 4.67
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.28Np Likeness Score: -1.04

References

1.  (2013)  Triazole compounds as KSP inhibitors, 

Source

Source(1):